Back to top

Image: Bigstock

Why Cullen/Frost Bankers (CFR) Stock Might be a Great Pick

Read MoreHide Full Article

One stock that might be an intriguing choice for investors right now is Cullen/Frost Bankers, Inc. (CFR - Free Report) . This is because this security in the Banks - Southwest space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Banks - Southwest space as it currently has a Zacks Industry Rank of 36 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Meanwhile, Cullen/Frost Bankers is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.

In fact, over the past month, current quarter estimates have risen from $1.24 per share to $1.28 per share, while current year estimates have risen from $5.10 per share to $5.28 per share. This has helped CFR to earn a Zacks Rank #2 (Buy), further underscoring the company’s solid position.You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So, if you are looking for a decent pick in a strong industry, consider Cullen/Frost Bankers. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Cullen/Frost Bankers, Inc. (CFR) - free report >>

Published in